TLR7 agonist 30 (compound 2) is a drug-linker conjugate used in ADCs. It comprises TLR7 agonist (compound 1) and a cleavable linker, exhibiting potent anti-tumor activity.
Molecular Weight:
1529.77
Formula:
C72H116N14O22
Target:
TLR|||Drug-Linker Conjugates for ADC
* VAT and and shipping costs not included. Errors and price changes excepted